HomeBusiness NewsTeva to pay $225 million in fines and divest generic drug to... Business NewsFinance August 22, 2023 Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges By George Karafotis Share FacebookTwitterPinterestWhatsApp - Advertisement - It’s the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product. … Share FacebookTwitterPinterestWhatsApp George Karafotishttp://revenuemastersagency.com - Advertisement - Stay Connected 16,985FansLike4,568FollowersFollow Must Read Business News Why automakers are turning to hybrids in the middle of the industry’s EV transition Christine - December 8, 2023 Business News 10-year Treasury yield jumps as unemployment rate unexpectedly declines December 8, 2023 Business News Paramount shares jump after reports of takeover interest December 8, 2023 Business News Trump PAC paid part of nearly $900,000 fee to fraud trial expert witness December 8, 2023 Related News Business News Why automakers are turning to hybrids in the middle of the industry’s EV transition December 8, 2023 Business News 10-year Treasury yield jumps as unemployment rate unexpectedly declines December 8, 2023 Business News Paramount shares jump after reports of takeover interest December 8, 2023 Business News Trump PAC paid part of nearly $900,000 fee to fraud trial expert witness December 8, 2023 Business News U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease December 8, 2023 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
